HSBC France ⬠20,000,000,000 Euro Medium Term Note Programme
HSBC France ⬠20,000,000,000 Euro Medium Term Note Programme
HSBC France ⬠20,000,000,000 Euro Medium Term Note Programme
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2<br />
This Base Prospectus (together with all supplements thereto from time to time) constitutes a base<br />
prospectus for the purposes of Article 5.4 of Prospectus Directive and contains all relevant information<br />
concerning the Issuer and the Issuer and its consolidated subsidiaries taken as a whole (the "Group")<br />
which is necessary to enable investors to make an informed assessment of the assets and liabilities,<br />
financial position, profit and losses and prospects of the Issuer, as well as the base terms and conditions of<br />
the <strong>Note</strong>s to be issued under the <strong>Programme</strong>. The terms and conditions applicable to each Tranche (as<br />
defined in " Summary of the Base Prospectus") not contained herein (including, without limitation, the<br />
aggregate nominal amount, the issue price, the redemption price thereof, and interest, if any, payable<br />
thereunder) will be determined by the Issuer and the relevant Dealer(s) at the time of the issue and will be<br />
set out in the relevant Final <strong>Term</strong>s.<br />
This Base Prospectus is to be read in conjunction with any document and/or information which is or may<br />
be incorporated herein by reference in accordance with Article 15 of the Loi relative aux prospectus pour<br />
valeurs mobilières dated 10 July <strong>20</strong>05 implementing the Prospectus Directive in Luxembourg and Article<br />
28 of the <strong>Euro</strong>pean Commission Regulation N°809/<strong>20</strong>04 dated 29 April <strong>20</strong>04 (see "Documents<br />
incorporated by Reference" below).<br />
This Base Prospectus may only be used for the purposes for which it has been published.<br />
No person is or has been authorised to give any information or to make any representation other than<br />
those contained in this Base Prospectus in connection with the issue or sale of the <strong>Note</strong>s and, if given or<br />
made, such information or representation must not be relied upon as having been authorised by the Issuer,<br />
the Arranger or any of the Dealers (as defined in "Summary of the Base Prospectus"). Neither the<br />
delivery of this Base Prospectus nor any sale made in connection herewith shall, under any circumstances,<br />
create any implication that there has been no change in the affairs of the Issuer or the Group since the<br />
date hereof or the date upon which this Base Prospectus has been most recently supplemented or that<br />
there has been no adverse change in the financial position of the Issuer or the Group since the date hereof<br />
or the date upon which this Base Prospectus has been most recently supplemented or that any other<br />
information supplied in connection with the <strong>Programme</strong> is correct as of any time subsequent to the date<br />
on which it is supplied or, if different, the date indicated in the document containing the same.<br />
The distribution of this Base Prospectus and the offering or sale of the <strong>Note</strong>s in certain jurisdictions may<br />
be restricted by law. Persons into whose possession this Base Prospectus comes are required by the Issuer,<br />
the Dealers and the Arranger to inform themselves about and to observe any such restriction.<br />
The <strong>Note</strong>s have not been and will not be registered under the United States Securities Act of 1933, as<br />
amended (the "Securities Act") or with any securities regulatory authority of any state or other<br />
jurisdiction of the United States and the <strong>Note</strong>s may include Materialised <strong>Note</strong>s in bearer form that are<br />
subject to U.S. tax law requirements. Subject to certain exceptions, the <strong>Note</strong>s may not be offered or sold<br />
or, in the case of Materialised <strong>Note</strong>s in bearer form, delivered within the United States or to, or for the<br />
account or benefit of, United States persons as defined in Regulation S under the Securities Act<br />
("Regulation S") or, in the case of certain Materialised <strong>Note</strong>s in bearer form, the U.S. Internal Revenue<br />
Code of 1986 and regulations thereunder. The <strong>Note</strong>s are being offered and sold outside the United States of<br />
America to non-U.S. Persons in reliance on Regulation S.<br />
This Base Prospectus has not been submitted to the clearance procedures of the Autorité des marchés<br />
financiers.<br />
For a description of these and certain further restrictions on offers, sales and transfers of <strong>Note</strong>s and on<br />
distribution of this Base Prospectus, see "Subscription and Sale".<br />
This Base Prospectus does not constitute an offer of, or an invitation by or on behalf of the Issuer, the<br />
Arranger or the Dealers to subscribe for, or purchase, any <strong>Note</strong>s.<br />
The Arranger and the Dealers have not separately verified the information contained in this Base<br />
Prospectus. Neither the Arranger nor any of the Dealers (except <strong>HSBC</strong> <strong>France</strong> in its capacity as Issuer,<br />
and then only to the extent set out under "Person responsible for the information given in the Base<br />
Prospectus") makes any representation, express or implied, or accepts any responsibility, with respect to<br />
the accuracy or completeness of any of the information in this Base Prospectus. Neither this Base<br />
Prospectus nor any other information supplied in connection with the <strong>Programme</strong> is intended to provide